US Patent 7220824 Integrin-mediated drug targeting
Patent 7220824 was granted and assigned to Bayer on May, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Andreas Schoop0
Hans-Georg Lerchen0
Jörg Baumgarten0
Markus Albers0
Thomas-J. Schulze0
Ulf Brüggemeier0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+450 characters)
Article
Patent abstract
The present invention relates to cytostatics which have a tumour-specific action as a result of linkage to αvβ3 integrin antagonists via preferred linking units. The preferred linking units guarantee serum stability of the conjugate of cytostatic and αvβ3 integrin antagonist and at the same time the desired intracellular action in tumour cells as a result of their enzymatic or hydrolytic cleavability with release of the cytostatic.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07220824 Integrin-mediated drug targeting US Patent 7220824 Integrin-mediated drug targeting
Infobox
Patent Number
072208240
Patent Number
72208240
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072208240
Date of Patent
May 22, 2007
0Patent Application Number
100702080
Date Filed
August 28, 2000
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07220824 Integrin-mediated drug targeting
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07220824
Date of patent
May 22, 2007
Patent application number
10070208
Date Filed
August 28, 2000
Patent primary examiner
Find more entities like US Patent 7220824 Integrin-mediated drug targeting
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
